Showing 18,941 - 18,960 results of 19,096 for search '(( 59 ((0 decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (nn decrease)) ))', query time: 1.01s Refine Results
  1. 18941

    Image_9_Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.JPEG by Cecilia Sgadari (120144)

    Published 2019
    “…Proviral DNA load decreased over time, with a half-life of 2 years and an estimated 90% reduction at year 8 in the Tat 30 μg, 3 × group. …”
  2. 18942

    Image_5_Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.JPEG by Cecilia Sgadari (120144)

    Published 2019
    “…Proviral DNA load decreased over time, with a half-life of 2 years and an estimated 90% reduction at year 8 in the Tat 30 μg, 3 × group. …”
  3. 18943

    Image_3_Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.JPEG by Cecilia Sgadari (120144)

    Published 2019
    “…Proviral DNA load decreased over time, with a half-life of 2 years and an estimated 90% reduction at year 8 in the Tat 30 μg, 3 × group. …”
  4. 18944

    Image_4_Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.JPEG by Cecilia Sgadari (120144)

    Published 2019
    “…Proviral DNA load decreased over time, with a half-life of 2 years and an estimated 90% reduction at year 8 in the Tat 30 μg, 3 × group. …”
  5. 18945

    Image_2_Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.JPEG by Cecilia Sgadari (120144)

    Published 2019
    “…Proviral DNA load decreased over time, with a half-life of 2 years and an estimated 90% reduction at year 8 in the Tat 30 μg, 3 × group. …”
  6. 18946

    Image_8_Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.JPEG by Cecilia Sgadari (120144)

    Published 2019
    “…Proviral DNA load decreased over time, with a half-life of 2 years and an estimated 90% reduction at year 8 in the Tat 30 μg, 3 × group. …”
  7. 18947

    Table_1_Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.DOCX by Cecilia Sgadari (120144)

    Published 2019
    “…Proviral DNA load decreased over time, with a half-life of 2 years and an estimated 90% reduction at year 8 in the Tat 30 μg, 3 × group. …”
  8. 18948

    Image_7_Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.JPEG by Cecilia Sgadari (120144)

    Published 2019
    “…Proviral DNA load decreased over time, with a half-life of 2 years and an estimated 90% reduction at year 8 in the Tat 30 μg, 3 × group. …”
  9. 18949

    Data_Sheet_1_Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.PDF by Cecilia Sgadari (120144)

    Published 2019
    “…Proviral DNA load decreased over time, with a half-life of 2 years and an estimated 90% reduction at year 8 in the Tat 30 μg, 3 × group. …”
  10. 18950

    Image_6_Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.JPEG by Cecilia Sgadari (120144)

    Published 2019
    “…Proviral DNA load decreased over time, with a half-life of 2 years and an estimated 90% reduction at year 8 in the Tat 30 μg, 3 × group. …”
  11. 18951

    Image_1_Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.JPEG by Cecilia Sgadari (120144)

    Published 2019
    “…Proviral DNA load decreased over time, with a half-life of 2 years and an estimated 90% reduction at year 8 in the Tat 30 μg, 3 × group. …”
  12. 18952

    Complex interaction networks of cytokines after transarterial chemotherapy in patients with hepatocellular carcinoma by Dong Wook Jekarl (6851633)

    Published 2019
    “…<div><p>Treating hepatocellular carcinoma with transarterial chemoembolization (TACE) induces both local inflammation in the tumor microenvironment as well as systemic inflammation. We analyzed serum cytokine response to TACE to evaluate this. …”
  13. 18953

    Image_2_The Selective Antagonism of Adenosine A2B Receptors Reduces the Synaptic Failure and Neuronal Death Induced by Oxygen and Glucose Deprivation in Rat CA1 Hippocampus in Vitr... by Irene Fusco (5134250)

    Published 2018
    “…Seven minutes OGD was applied in the presence of the selective adenosine A<sub>2B</sub> receptor antagonists MRS1754 (500 nM) or PSB603 (50 nM), separately administered 15 min before, during and 5 min after OGD. …”
  14. 18954

    Predicted growth rates for <i>S. bayanus</i> and <i>S. pombe</i> expression datasets. by Edoardo M. Airoldi (268357)

    Published 2009
    “…<p>By examining genes orthologous to our ∼70 <i>S. cerevisiae</i> growth-specific calibration genes, we successfully applied our model to predict growth rates in <i>S. bayanus</i> (∼50 orthologous growth-specific genes, ∼20 M years diverged) and <i>S. pombe</i> (∼75 growth-specific genes due to one-to-many mappings, ∼1B years diverged). …”
  15. 18955

    Genome-wide miRNA response to anacardic acid in breast cancer cells by David J. Schultz (4423906)

    Published 2017
    “…Anacardic acid (AnAc) is a dietary phenolic lipid that inhibits both MCF-7 estrogen receptor α (ERα) positive and MDA-MB-231 triple negative breast cancer (TNBC) cell proliferation with IC<sub>50</sub>s of 13.5 and 35 μM, respectively. To identify potential mediators of AnAc action in breast cancer, we profiled the genome-wide microRNA transcriptome (microRNAome) in these two cell lines altered by the AnAc 24:1n5 congener. …”
  16. 18956

    DataSheet1_Photochemical Reactivity of Humic Substances in an Aquatic System Revealed by Excitation-Emission Matrix Fluorescence.docx by Xin-yuan Wang (10888515)

    Published 2021
    “…<p>The photochemical reactivity of humic substances plays a critical role in the global carbon cycle, and influences the toxicity, mobility, and bioavailability of contaminants by altering their molecular structure and the mineralization of organic carbon to CO<sub>2</sub>. Here, we examined the simulated irradiation process of Chinese standard fulvic acid (FA) and humic acid (HA) by using excitation-emission matrix fluorescence combined with fluorescence regional integration (FRI), parallel factor (PARAFAC) analysis, and kinetic models. …”
  17. 18957

    DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Con... by Melanie Thompson (207727)

    Published 2016
    “…Nine men who began antiretroviral therapy (ART) within 18 months of seroconversion and had sustained plasma HIV-1 RNA <50 copies/mL for at least 6 months were enrolled. …”
  18. 18958

    Reduced TBSV repRNA accumulation in yeast with depleted Pgk1 level. by K. Reddisiva Prasanth (693252)

    Published 2017
    “…<p>(A) Northern blot analysis shows decreased TBSV repRNA accumulation in a yeast strain (GALS::PGK1) when Pgk1 was depleted. …”
  19. 18959

    A missense variant in <i>FTCD</i> is associated with arsenic metabolism and toxicity phenotypes in Bangladesh by Brandon L. Pierce (181635)

    Published 2019
    “…To identify additional arsenic metabolism loci, we measured protein-coding variants across the human exome for 1,660 Bangladeshi individuals participating in the Health Effects of Arsenic Longitudinal Study (HEALS). …”
  20. 18960

    Table_2_Impact of traditional Chinese Baduanjin exercise on menstrual health among international female students studying in China: a randomized controlled trial.DOC by Asem Alkhatib (11244708)

    Published 2024
    “…In addition, the results of the MANOVA indicated statistically significant decreases in scores for the two subscales of MSQ: premenstrual symptoms (intervention: 17.07 ± 3.33 vs. control: 28.42 ± 7.56; F = 44.70, P < 0.01)and menstrual pain (16.03 ± 4.53 vs. 19.58 ± 5.14; F = 6.50, P < 0.05). …”